Industry must show Commission way forward - or risk product approvals future
This article was originally published in Clinica
Executive Summary
The medtech sector has a maximum of five months to come up with a coherent argument as to how to improve the current medical device regulatory system. If it does not, it can expect the Commission to present once again proposals as radical as those contained in the contentious and much opposed consultation on the proposed recast of the medical device directives.